C
CNS Pharmaceuticals D
D
CNSP
0.81560
USD
0.00
(0.32%)
مغلق
حجم التداول
300
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
4,454,767
الأخبار المقالات
العنوان: CNS Pharmaceuticals Inc.
القطاع: Healthcare
الصناعة: Biotechnology
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.